AstraZeneca waiting for FDA to greenlight restart of US drug trial
AstraZeneca says it's still waiting on federal approval to resume the U.S. clinical trial of its COVID-19 vaccine candidate nearly three weeks after the study was halted over safety concerns.
Best Dslr Camera under 200 via FOX BUSINESS NEWS Markets
https://ift.tt/32ZiV60
0 Comments:
Post a Comment